It was proposed that inhibition of the myostatin pathway in mice results in resistance to develop high-fat diet-induced and genetic obesity, suggesting a potential role for myostatin inhibition in the treatment of obesity and diabetes (e.g. [37]). This evidence concerns the gene MSTN and obesity due to melanocortin 4 receptor deficiency.